In conclusion, these findings suggested that ISG20 promoted cell proliferation and metastasis via regulating MMP9/CCND1 expression and might serve as a potential biomarker and therapeutic target in ccRCC. This evidence concerns the gene CCND1 and nonpapillary renal cell carcinoma.